Faculty

Share

The Gerstner Sloan Kettering faculty brings together outstanding scientists and engineers working at the forefront of biomedical research and cancer engineering. Browse our list of Faculty and learn more about each faculty member’s area of investigation.

Faculty members who do not serve as dissertation mentors but who make contributions to the education of our students by teaching or serving as clinical mentors are appointed as Gerstner Sloan Kettering Special Contributing Faculty.

and/or
136 Faculty Members found
Molecular Pharmacology Program
Neal Rosen Lab Group
Neal Rosen, MD, PhD
Professor
Pharmacologist Neal Rosen focuses on understanding biochemical mechanisms underlying phenotypes caused by tyrosine kinase activation in epithelial tumors and developing new therapeutic strategies.
  • MD, PhD, Albert Einstein College of Medicine
Immunology Program
The Alexander Rudensky Lab
Alexander Rudensky, PhD
Professor
Immunology Program Chair Alexander Rudensky focuses on immunological tolerance and the differentiation and function of T cells.
  • PhD, Gabrichevsky Institute for Microbiology and Epidemiology
Memorial Hospital Research Laboratories
The Charles Rudin Lab
Charles M. Rudin, MD, PhD
Professor
Physician-scientist Charles Rudin focuses on the development and testing of novel therapeutic approaches to lung cancer in preclinical models.
  • MD, PhD, University of Chicago Pritzker School of Medicine
Immunology Program
Michel Sadelain Lab Group
Michel Sadelain, MD, PhD
Professor
Immunologist Michel Sadelain studies the mechanisms governing transgene expression, stem cell engineering, and genetic strategies to enhance immunity against cancer.
  • MD, University of Paris
  • PhD, University of Alberta
Human Oncology & Pathogenesis Program
The Charles Sawyers Lab
Charles L. Sawyers, MD
Professor
Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.
  • MD, Johns Hopkins University School of Medicine
Molecular Pharmacology Program
The David Scheinberg Lab
David A. Scheinberg, MD, PhD
Professor
Molecular Pharmacology Program Member David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.
  • MD, PhD, Johns Hopkins University School of Medicine
Immunology Program
Andrea Schietinger lab
Andrea Schietinger, PhD
Associate Professor
Cancer Immunologist Andrea Schietinger investigates immune responses to cancer, molecular mechanisms underlying tumor-induced T cell dysfunction, and new approaches for cancer immunotherapy.
  • PharmD, University of Hamburg, PhD, University of Chicago, Chicago, IL and University of Munich, Germany
  • Postdoctoral Training: Fred Hutchinson Cancer Research Center and University of Washington, Seattle
Epidemiology & Biostatistics
Nikolaus Schultz Lab
Nikolaus Schultz, PhD
Professor
Cancer biologist Nikolaus Schultz uses computational tools to study the diversity of genomic alterations underlying different cancer types.
  • PhD, Freie Universitat Berlin
Molecular Biology Program
Agnel Sfeir, PhD
Professor
The Sfeir Lab investigates pathways that ensure genome fidelity and plasticity.
  • PhD, UT Southwestern Medical Center, Texas (2006)
  • Post-Doc, The Rockefeller University, New York (2011)
Epidemiology & Biostatistics
Sohrab Shah Lab Group
Sohrab Shah, PhD
Professor
The Shah lab focuses on the major topics of cancer evolution, single cell genomics and transcriptomics, mutational processes and prediction of drug response.
  • PhD, University of British Columbia (Canada)